Karolinska Development1,66SEK +0,85%
Karolinska Development is a Nordic investment company in the life science sector. The company focuses on identifying medical innovations to create and develop companies that further develop such innovations into differentiated products. Karolinska Development's portfolio consists of a number of companies focused on developing treatment methods for diseases that are classified as life-threatening and serious. The largest business operations are in the Nordic market.
Major OwnersSource: Millistream Market Data AB
|invoX Pharma Ltd
|Worldwide International Investments Ltd